News

Upbeat BidCo Plans Public Buy-Out Offer for Believe Shares

Upbeat BidCo Plans Public Buy-Out Offer for Believe Shares

Upbeat BidCo's Intent to Acquire Believe Shares

Upbeat BidCo, the majority shareholder of Believe, has expressed its intention to file a public buy-out offer for the remaining shares it does not currently hold. This move signals a commitment to consolidate ownership and enhance operational efficiencies within Believe. The transaction will also be accompanied by a squeeze-out for minority shareholders.

Details of the Offering

The anticipated buy-out offer is set at a price of 15.30 euros per share. This price is attractive as it incorporates premiums of 2.9%, 4.4%, 7.5%, and 6.0% over the 30-day, 60-day, 120-day, and 180-day volume-weighted average prices respectively, as determined prior to the announcement.

Formation of an Ad-Hoc Committee

In conjunction with this offer, Believe’s Board of Directors has established an ad-hoc committee comprised of three independent directors aimed at ensuring a fair and transparent process. This committee will be pivotal in overseeing the valuation of the offer and will work closely with Finexsi, appointed as the independent expert to evaluate these terms.

Strategic Implications for Believe

The Board has responded positively to Upbeat BidCo’s proposal, contingent upon a thorough review of its financial terms. Given that Upbeat BidCo already controls 96.65% of Believe’s equity, this move is likely to streamline operations and align the business more closely with its strategic goals.

Expert Oversight

Finexsi will prepare a report assessing the fairness of the offer price and ensure that no arrangements affect the treatment of all shareholders equally. This independent oversight is crucial, particularly in light of the sensitive nature of ownership consolidation.

Timeline and Expected Outcomes

The buy-out offer is expected to be officially submitted shortly and is anticipated to open in the second quarter of the coming year, pending clearance from regulatory bodies. Following the offer, Upbeat BidCo plans to execute a squeeze-out of the remaining minority shareholders, who collectively own less than 10% of the shares.

Compensation for Minority Shareholders

Shareholders who will be affected by the squeeze-out will receive compensation at the same price offered in the buy-out, fostering an equitable resolution for all stakeholders involved.

About Upbeat BidCo and Its Leadership

Upbeat BidCo is controlled by Denis Ladegaillerie, the founder and CEO of Believe, indicating a strong alignment of interests among the major stakeholders. This proposal reflects the commitment to expanding the company's reach and supporting its long-term growth vision.

Profile of Believe

Believe is recognized as a leading player in the digital music industry, dedicated to empowering independent artists and labels by providing essential resources and growth strategies tailored to the evolving music landscape. It consists of a strong team spread across numerous countries, promoting a collaborative environment for artists to thrive.

Frequently Asked Questions

What is the purpose of Upbeat BidCo's buy-out offer?

The primary purpose is to consolidate ownership of Believe and enhance its operational effectiveness by acquiring the remaining shares.

What price is being offered to shareholders?

Upbeat BidCo is offering shares at a price of 15.30 euros, which reflects significant premiums over prior trading averages.

Who will oversee the fairness of the offer?

An independent expert, Finexsi, has been appointed to ensure the offer is fair and equitable among all shareholders.

What happens to minority shareholders following the squeeze-out?

Minority shareholders will receive compensation equivalent to the buy-out offer price during the squeeze-out process.

How will this impact the future of Believe?

This acquisition is expected to align Believe's operations more closely with its strategic aims and foster sustainable growth within the digital music industry.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 4

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading

Top 5 Most Recently Viewed Articles

SKK Holdings Limited Announces Pricing for Share IPO Offering

Updated Category News Views 65

SKK Holdings Limited Announces Share Pricing for IPO SKK Holdings Limited (“SKK” or the “Company”) (Nasdaq: SKK), a specialized civil engineering service provider in subsurface utility works, has proudly announced the pricing of its initial public offering. The Company will offer 2,500,000 ordinary shares at a public offering price of $4.00 per share, yielding...

Continue Reading
Antelope Enterprise: Financial Performance Insights for 2024

Updated Category News Views 149

Antelope Enterprise Holdings Limited (NASDAQ: AEHL) hit the financial report stage hard back in mid-2024, flaunting numbers that tell quite the tale of both triumphs and tribulations. This company was hustling across two growing fronts: the fast-paced world of livestreaming ecommerce and the burgeoning energy sector down in Texas. Their half-year performance review...

Continue Reading
Olivier Falut Steps Into CFO Role at EUROAPI to Drive Growth

Updated Category News Views 344

Olivier Falut Joins EUROAPI as the New Chief Financial Officer EUROAPI is excited to announce the appointment of Olivier Falut as its new Chief Financial Officer, effective immediately. Olivier will be an integral member of the Executive Committee, succeeding Evelyne Nguyen. Evelyne will ensure continuity and a smooth transition within the company through her support...

Continue Reading
OPEXUS and Casepoint Join Forces for Growth and Innovation

Updated Category News Views 261

OPEXUS and Casepoint Unite for Strategic Growth In a significant development in the technology sector, OPEXUS, a frontrunner in government process management software, and Casepoint, an innovator in data discovery technology, have announced their merger. This significant move comes along with a majority investment from Thoma Bravo, a renowned software investment firm...

Continue Reading
MeiraGTx Holdings: An In-Depth Look at Future Potential

Updated Category News Views 69

MeiraGTx Holdings plc (NASDAQ:MGTX) was a clinical-stage gene therapy firm making waves back in 2024. The company announced a pivotal financial move, securing $50 million through equity financing at $4 per share, largely thanks to a $30 million investment from Sanofi (NYSE:SNY). While this funding boosted MGTX’s war chest, traders were already whispering about the heavy...

Continue Reading